GHR and acromegaly: GH results in decreased expression of p53, PTEN, and APC in human non-tumorous colon cells and 3-dimensional human intestinal organoids, while suppressing GH signaling with the GH receptor (GHR) antagonist pegvisomant led to p53 induction in colon tissue of acromegaly patients (15).